Welcome to our dedicated page for Orchid Island Capital SEC filings (Ticker: ORC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Orchid Island Capital, Inc. filings document a mortgage REIT focused on leveraged investments in Agency RMBS. The company’s Form 8-K reports record quarterly results, estimated book value, RMBS portfolio characteristics, monthly dividend declarations, realized and unrealized results on RMBS and derivative instruments, interest rate swap activity, liquidity and repurchase agreement financing.
Proxy filings cover board matters, executive compensation and shareholder voting for the Maryland corporation. The filing record also reflects the company’s REIT distribution framework, common-stock dividend disclosures, externally managed structure through Bimini Advisors, LLC, and recurring risk and governance subjects tied to mortgage securities, leverage and interest-rate exposure.
Frank P. Filipps, a director of Orchid Island Capital, Inc. (ORC), reported a Form 4 showing he was granted 3,566 deferred stock units on 10/01/2025. Each deferred stock unit represents a right to receive one share of the company’s common stock and the units are stated to be 100% vested. The deferred units do not become payable until the earlier of a change of control or the reporting person’s death, disability, or separation from service as a director. After this grant, the Form 4 reports total beneficial ownership of 43,256 shares. The filing was signed on 10/02/2025.
Orchid Island Capital director Paula Morabito reported acquiring 3,566 deferred stock units on 10/01/2025. Each unit equals one share of common stock and the units are 100% vested, but payment is deferred until the earlier of a change of control, the reporting person's death or disability, or separation from service as a director. After this transaction, the reporting person beneficially owns 45,067 shares of Orchid Island Capital common stock. The filing is a Form 4 reporting an insider non-derivative acquisition of deferred compensation units.
W. Coleman Bitting, a director of Orchid Island Capital, Inc. (ORC), reported receiving 3,566 deferred stock units on 10/01/2025. Each unit represents a right to one share of the company's common stock and carries a stated price of $0. After this grant, Mr. Bitting beneficially owns 43,256 shares (direct). The deferred stock units are fully vested but are payable only upon a specified triggering event: the earlier of a change of control or the reporting person’s death, disability, or separation from service as a director. The Form is signed on 10/02/2025.
Ava L. Parker, a director of Orchid Island Capital, Inc. (ORC), reported three grants of deferred stock units on 09/30/2025 and 10/01/2025.
The filings show 1,553 DSUs issued on 09/30/2025 in lieu of the monthly dividend at an attributable value of $6.91 per unit, plus two grants on 10/01/2025 of 3,566 DSUs (no price listed) and 2,050 DSUs granted in lieu of cash compensation with an attributable value of $7.01 per unit. Following these transactions the reporting person beneficially owned 96,636 shares.
The DSUs are fully vested but payable only upon a change of control or the reporting person's death, disability, or separation from service as a director.
Orchid Island Capital director and CFO G. Hunter Haas, IV reported transactions on 09/26/2025 reflecting the vesting of Performance Units and a related withholding sale. 3,031.72 Performance Units vested and were converted into 3,031 shares of common stock (cash paid for fractional shares). To satisfy tax withholding on the vesting, 1,133 shares were transferred back to the issuer at a closing price of $6.99 per share. After these transactions the reporting person directly beneficially owned 75,600 shares of common stock and held performance-unit-based derivative interests equal to 3,031.72 underlying shares, with 13,851.11 derivative securities reported as beneficially owned following the transactions.
Orchid Island Capital CEO Robert E. Cauley reported vesting-related share activity. Performance Units vested into 3,694 shares of common stock from awards granted in 2023 and 2024. Separately, 742 shares were surrendered to the company for tax withholding at $6.99 per share. After these events, he directly holds 144,554 common shares.
Orchid Island Capital, Inc. filed a Current Report on Form 8-K that discloses an exhibit: a press release dated September 8, 2025. The filing identifies the company as a Maryland corporation trading common stock under the ticker ORC on the NYSE and states the exhibit is included under Item 9.01 (Financial Statements and Exhibits). The report is signed by Robert E. Cauley, Chairman and Chief Executive Officer. No financial tables, earnings figures, transactions, or additional narrative are included in this filing; it functions primarily to attach the press release as an exhibit.
Ava L. Parker, a director of Orchid Island Capital, Inc. (ORC), reported receipt of 1,493 deferred stock units on 08/28/2025 issued in lieu of her monthly dividend election. Each deferred stock unit equals one share of the issuer's common stock and the filing reports 89,467 shares beneficially owned by Ms. Parker after the transaction. The units are fully vested but are not payable until the earlier of a change of control, death, disability, or separation from service as a director.
Orchid Island Capital, Inc. announced a cash dividend of $0.12 per share for August 2025, payable on September 29, 2025 to holders of record on August 29, 2025 with an ex-dividend date of August 29, 2025. The Board declared the distribution and the company attached a press release describing the dividend and additional company information as Exhibit 99.1.
The filing also states the company disclosed certain details of its residential mortgage-backed securities (RMBS) portfolio as of July 31, 2025, with those specifics provided in the attached press release. The report includes the company’s standard caution about forward-looking statements and notes investors should refer to the Company’s risk disclosures for factors that could affect future outcomes.